Ercan Müldür

780 total citations
13 papers, 276 citations indexed

About

Ercan Müldür is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Ercan Müldür has authored 13 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Ercan Müldür's work include Multiple Myeloma Research and Treatments (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Gastric Cancer Management and Outcomes (2 papers). Ercan Müldür is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Gastric Cancer Management and Outcomes (2 papers). Ercan Müldür collaborates with scholars based in Austria, Czechia and Germany. Ercan Müldür's co-authors include Heinz Ludwig, Georg Endler, Wolfgang Hübl, Niklas Zojer, Alois Lang, Johannes Drach, Wolfgang Lamm, Wolfgang Willenbacher, C C Zielinski and Daniel Heintel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Ercan Müldür

10 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ercan Müldür Austria 5 170 90 87 70 27 13 276
M. Puntous France 11 220 1.3× 52 0.6× 70 0.8× 95 1.4× 42 1.6× 34 318
Liselotte S. Ebbesen Denmark 8 412 2.4× 105 1.2× 41 0.5× 19 0.3× 63 2.3× 10 510
Magnus Adriansson Sweden 5 446 2.6× 92 1.0× 172 2.0× 185 2.6× 75 2.8× 7 508
Franck Lellouche France 8 194 1.1× 133 1.5× 24 0.3× 10 0.1× 6 0.2× 25 348
Sarah T.B.G. Loubele Netherlands 6 239 1.4× 66 0.7× 30 0.3× 10 0.1× 4 0.1× 8 361
Sigvard Olsson Sweden 8 141 0.8× 97 1.1× 45 0.5× 24 0.3× 4 0.1× 10 344
Evgeny Shutov Russia 5 291 1.7× 123 1.4× 40 0.5× 6 0.1× 75 2.8× 15 402
Wenzhong Que China 9 116 0.7× 29 0.3× 100 1.1× 38 0.5× 125 4.6× 18 361
Elizabeth A. Swallow United States 12 36 0.2× 20 0.2× 86 1.0× 69 1.0× 5 0.2× 32 325
H. -P. Lohrmann Germany 9 173 1.0× 27 0.3× 17 0.2× 106 1.5× 57 2.1× 23 303

Countries citing papers authored by Ercan Müldür

Since Specialization
Citations

This map shows the geographic impact of Ercan Müldür's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ercan Müldür with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ercan Müldür more than expected).

Fields of papers citing papers by Ercan Müldür

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ercan Müldür. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ercan Müldür. The network helps show where Ercan Müldür may publish in the future.

Co-authorship network of co-authors of Ercan Müldür

This figure shows the co-authorship network connecting the top 25 collaborators of Ercan Müldür. A scholar is included among the top collaborators of Ercan Müldür based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ercan Müldür. Ercan Müldür is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Reichinger, Andreas, Kathrin Strasser‐Weippl, Holger Rumpold, et al.. (2022). High mortality in patients with active malignancy and severe COVID-19. memo - Magazine of European Medical Oncology. 15(2). 153–160. 1 indexed citations
2.
Müldür, Ercan & Wolfgang Hilbe. (2021). Practice-changing strategies in the treatment of esophageal cancer. memo - Magazine of European Medical Oncology. 15(1). 35–38.
3.
Hilbe, Wolfgang, et al.. (2020). Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer. memo - Magazine of European Medical Oncology. 13(3). 337–340.
4.
Müldür, Ercan, et al.. (2019). The path of an esophageal carcinoma patient from curative to palliative treatment. memo - Magazine of European Medical Oncology. 12(1). 60–62.
5.
Bolomsky, Arnold, Wolfgang Hübl, Stefano Spada, et al.. (2017). IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide‐dexamethasone therapy in multiple myeloma. American Journal of Hematology. 92(3). 269–278. 11 indexed citations
6.
Gebhart, Johanna, Klaus Lechner, Cathrin Skrabs, et al.. (2014). Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma. Thrombosis Research. 134(5). 980–984. 13 indexed citations
7.
Ludwig, Heinz, Elisabeth Rauch, Zdeněk Adam, et al.. (2014). Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study. Haematologica. 100(3). 385–391. 19 indexed citations
8.
Ludwig, Heinz, Elisabeth Rauch, Zdeněk Adam, et al.. (2014). Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study. Blood. 124(21). 3484–3484. 1 indexed citations
9.
Ludwig, Heinz, Ercan Müldür, Georg Endler, & Wolfgang Hübl. (2013). Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Annals of Oncology. 24(7). 1886–1892. 178 indexed citations
10.
Ludwig, Heinz, H. Kasparu, Richard Greil, et al.. (2012). Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated. Blood. 120(21). 943–943. 3 indexed citations
11.
Müldür, Ercan, Andreas Chott, Siroos Mirzaei, Niklas Zojer, & Heinz Ludwig. (2011). Patient With High-Grade Fever, Night Sweats, and Hepatosplenomegaly. Journal of Clinical Oncology. 29(10). e254–e256. 1 indexed citations
12.
Lamm, Wolfgang, Wolfgang Willenbacher, Alois Lang, et al.. (2010). Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis. Annals of Hematology. 90(2). 201–206. 47 indexed citations
13.
Lamm, Wolfgang, Wolfgang Willenbacher, Niklas Zojer, et al.. (2009). Efficacy of the Combination of Bortezomib and Dexamethasone in Systemic AL Amyloidosis.. Blood. 114(22). 2871–2871. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026